VolitionRx Ltd (NYSE:VNRX) A Leader in Epigenetic Blood Test Innovat...

Highlights,VolitionRx focuses on epigenetics to aid in early cancer and disease detection.,Company’s market cap stands at $56.99 million with a P/E ra...

Why Is This AML Trial Raising Serious Questions About Current Treatm...

Highlights,Hemogenyx initiates clinical trial for HG-CT-1 in treating R/R AML.,Focus on evaluating safety and effects on survival and disease progress...

CEL-SCI (NYSE: CVM) Announces Public Offering to Support Multikine D...

Highlights,CEL-SCI plans to raise capital to fund continued development of Multikine cancer therapy.,ThinkEquity appointed as sole placement agent for...

CVS Health Faces Challenges as Earnings Decline Weighs on Stock Perf...

Headlines,CVS Health's performance has seen significant challenges, with recent declines raising concerns.,The company's price-to-earnings ratio indic...

The Impact of Market Volatility on Waters Corporation (NYSE:WAT)

Highlights,Impressive 17% price growth in recent months for Waters Corporation.,Fair valuation of the stock, priced 8.9% below its intrinsic value.,Hi...

Viracta Therapeutics Explores Strategic Alternatives Amid Trial Clos...

Highlights,Viracta Therapeutics announces it is exploring strategic alternatives, including mergers, licensing, or sales.,The company has decided to v...

Chemed’s (NYSE:CHE) Stock Hits a 52-Week Low Amid Financial Struggle...

Highlights,Chemed’s stock hits a 52-week low of $517.44, down 1.1%.,Company missed analysts’ earnings expectations for the latest quarter.,Dividend pa...

Why Did Geode Capital Increase Holdings in Ligand Pharmaceuticals?

Highlights,Geode Capital increases its stake in Ligand Pharmaceuticals.,Ligand Pharmaceuticals operates in the biotechnology sector.,SEC filing reveal...

Why Did NeoGenomics Surpass Market Projections This Quarter?

Highlights:,Quarterly revenue reached $167.8 million, showing growth.,EPS reported at $0.05, surpassing expectations.,Market capitalization stands at...

Why Is Biogen Struggling to Maintain Stability in the Market?

Highlights,Market Cap stands at $21.77 billion for Biogen Inc.,52-week range between $145.07 and $268.30.,Current ratios: Quick ratio of 0.80 and curr...

AVITA Medical (NASDAQ: RCEL) Receives FDA Approval for RECELL GO Min...

Highlights,FDA approval for RECELL GO mini expands AVITA Medical's product portfolio.,New cartridge is optimized for treating smaller wounds, enhancin...

Principal Financial Group Expands Stake in Centene Co.

Headlines,Principal Financial Group Inc. has expanded its ownership in Centene Co.,(NYSE:CNC),.,Institutional investors and hedge funds maintain signi...

Why Is MaxCyte Losing a Longstanding Board Member This Year?

Highlights,MaxCyte announces the retirement of Art Mandell from its Board.,Board member Mandell played a key role in company milestones.,Board to cons...

Why Is This Biotech Stock Making Headlines Before the Market Opens?

Highlights,Alvotech added to Nasdaq Biotechnology Index during annual reconstitution.,Inclusion based on market capitalization and daily trading volum...

Why Are Intra-Cellular Therapies Shares Struggling to Maintain Momen...

Highlights,Intra-Cellular Therapies operates within the dynamic biopharmaceutical sector.,The company focuses on treatments addressing complex mental...

Eli Lilly’s (NYSE: LLY) Zepbound (tirzepatide) Receives FDA Approval...

Highlights,Zepbound (tirzepatide) is the first FDA-approved prescription for OSA with obesity.,Patients experienced up to 20% weight loss and 25 fewer...

UnitedHealth Group's (NYSE:UNH) Operational Efficiency and Market Pr...

Highlights,UnitedHealth Group returns plateauing after strong performance.,ROCE remains stable at 16% despite increased capital employment.,Steady rei...

Will the falling Hims & Hers stock price recover in 2025?

Hims & Hers stock price has greatly performed this year as it continued to disrupt the healthcare industry. HIMS has jumped by almost 200% this ye...

Analyzing Haemonetics (NYSE:HAE) Earnings and Share Price Dynamics

Highlights,Haemonetics share price increase by 42% over three years,EPS growth of 59% per year outpaces share price increase,Market expectations for H...

Dental and Medical Innovations at Milestone Scientific (NYSE:MLSS)

Highlights,Increased holdings in Milestone Scientific by hedge funds and institutions.,Advanced injection technologies for medical, dental, and cosmet...